Search
Search Results
##search.searchResults.foundPlural##
-
-
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5728PDF: 1565HTML: 1661Untitled: 257 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3443PDF: 2039HTML: 7572 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1402PDF: 486HTML: 18624Figure 1: 185Figure 2: 165Figure 3: 183Figure 4: 219Figure 5: 194 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1248PDF: 880HTML: 113 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
955PDF: 710HTML: 258 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
1034PDF: 784HTML: 124 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7819PDF: 2481HTML: 2115Table 1.: 246Table 2.: 257Table 3.: 237Table 4.: 232 -
PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
2549PDF: 905HTML: 2403 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1322PDF: 996HTML: 439 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3339PDF: 1064HTML: 2380 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3143PDF: 1052HTML: 3191 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1284PDF: 970HTML: 344 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1466HTML: 641PDF: 876 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1103PDF: 584HTML: 7881 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4167PDF: 1296HTML: 2118Table 1: 219 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2649PDF: 977HTML: 581 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1441PDF: 783HTML: 539 -
ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia
1358PDF: 764HTML: 286 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1379PDF: 782HTML: 408 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4364PDF: 1566HTML: 469







